Key papers, reviewed

Corrected the widely cited 10:1 bacterial-to-human cell ratio to approximately 1:1 for a 70 kg reference male, fundamentally changing how the field frames the microbiome's scale.

• 01~3.8×10¹³ bacteria vs ~3.0×10¹³ human cells — ratio is ~1.3:1
• 02Colon contains the vast majority of bacteria
• 03The old 10:1 figure traced to a single 1972 estimate that was never validated

Essential corrective. The 1:1 figure doesn't diminish the microbiome's importance — it just removes a false factoid that was used to inflate it.

Characterized microbiome composition across 18 body sites in 242 healthy adults, establishing reference data for the field.

• 01Body-site specificity is stronger than interpersonal variation
• 02Functional gene profiles are more conserved than taxonomic composition
• 03Healthy microbiomes are highly variable between individuals

Foundational reference dataset but skewed toward US adults of limited ethnic diversity. Functional stability despite taxonomic variation is a key insight.

First high-quality RCT of FMT vs vancomycin for recurrent CDI. Trial stopped early for efficacy — FMT cured 81% vs 31% for vancomycin.

• 01FMT via nasoduodenal tube cured 81% after first infusion, 94% after second
• 02Vancomycin alone cured only 31%
• 03Trial stopped early by DSMB for overwhelming efficacy

Small (n=43) but decisive. Open-label design was unavoidable. Established FMT as the standard of care for rCDI.

Showed that melanoma patients responding to anti-PD-1 had higher gut microbial diversity and enrichment of Faecalibacterium; FMT from responders to germ-free mice enhanced anti-tumor immunity.

• 01Responders had higher diversity and Faecalibacterium abundance
• 02FMT from responders to GF mice slowed tumor growth
• 03Provided rationale for FMT-immunotherapy combination trials

Correlational in humans; causal in mouse model. Specific taxa vary across studies (Akkermansia in Routy, Bifidobacterium in Matson). Pattern is real, details are noisy.

Showed that probiotic colonization is person-specific — some hosts resist colonization entirely. Higher baseline diversity predicted resistance.

• 01Mucosal colonization of probiotics varies dramatically between individuals
• 02Stool analysis poorly predicts mucosal colonization
• 03Colonization resistance correlates with baseline diversity

Small but methodologically outstanding (endoscopic sampling). Explains why probiotic trials show such variable results.

10-week RCT comparing high-fermented-food vs high-fiber diets. Fermented foods increased diversity and decreased inflammatory markers; fiber increased SCFA production without short-term diversity change.

• 01Fermented foods increased microbial diversity
• 0219 inflammatory markers decreased in the fermented food group
• 03High-fiber diet increased SCFA capacity but not short-term diversity

Well-designed but short duration and small sample. Fermented food results are compelling; fiber effects may need longer interventions.

Defined the five community state types (CSTs) of the vaginal microbiome and revealed significant racial/ethnic variation in Lactobacillus dominance patterns.

• 01Five CSTs: four Lactobacillus-dominant (I, II, III, V) and one diverse (IV)
• 02CST-IV more prevalent in Black and Hispanic women
• 03Challenged the universality of Lactobacillus dominance as 'healthy'

Foundational classification still used. Raised important equity questions about defining 'normal' from predominantly white cohorts.

Authoritative review covering the pathways, mechanisms, and clinical implications of gut-brain communication via the microbiome.

• 01Four pathways: neural (vagal), immune, endocrine (HPA), metabolic (SCFAs, tryptophan)
• 02Strong preclinical evidence; human translation lagging
• 03Coined/popularized 'psychobiotics' framework

Excellent as a reference; acknowledges the preclinical-to-clinical translation gap honestly. Required reading for anyone in the field.

Demonstrated that technical factors (DNA extraction, sequencing platform, bioinformatics pipeline) introduce more variation than biological differences between individuals.

• 01DNA extraction method was the largest source of variation
• 02Bioinformatics pipeline choice significantly affected results
• 03Standardization is essential for cross-study comparisons

Critical reality check for the field. Should be required reading before interpreting any microbiome study.

AGA conditional recommendations for specific probiotic strains in specific conditions; recommended against probiotics for most GI indications due to insufficient evidence.

• 01Conditional recommendation for S. boulardii for C. diff prevention
• 02Conditional for specific strains in pouchitis
• 03Recommended AGAINST probiotics for Crohn's, most IBS, and general gut health

Sober, evidence-based. The gap between these recommendations and consumer marketing is enormous.

Showed that probiotics taken after antibiotics actually delayed native microbiome recovery compared to spontaneous recovery or autologous FMT.

• 01Probiotics colonized the antibiotic-cleared gut but delayed native community return
• 02Autologous FMT (own pre-antibiotic stool) restored the microbiome fastest
• 03Stool analysis poorly reflected mucosal colonization dynamics

Companion to Zmora 2018. Small but methodologically rigorous. Challenges the 'probiotics after antibiotics' dogma. Key message: probiotics can interfere with recovery.

Tracked microbiome recovery in healthy adults after a cocktail of 3 antibiotics over 6 months. Most species recovered but 9 common species remained undetectable at 180 days.

• 01Most gut species recovered within 1.5 months
• 029 common species were still undetectable at 6 months
• 03Antibiotic resistance genes expanded during treatment and persisted

Important timeline data. The unrecovered species question — are they truly lost or below detection? — remains open. The 3-antibiotic cocktail is more extreme than typical clinical use.

Demonstrated that vaginally delivered newborns acquire Lactobacillus-dominated communities while C-section babies acquire skin-flora communities (Staphylococcus, Propionibacterium).

• 01Vaginal birth: Lactobacillus, Prevotella, Sneathia-dominated initial colonization
• 02C-section: Staphylococcus, Corynebacterium, Propionibacterium-dominated
• 03Differences detectable across multiple body sites immediately after birth

Foundational for the birth-mode-microbiome field. Small sample (n=10) but consistently replicated. Long-term clinical significance of these early differences is still debated.

Showed that common food emulsifiers (CMC, P80) erode the mucus layer, increase bacterial translocation, and promote inflammation and metabolic syndrome in mice.

• 01Emulsifiers thinned the protective mucus layer
• 02Bacteria encroached closer to the epithelium
• 03Promoted low-grade inflammation and metabolic changes in wild-type mice; colitis in susceptible models

Influential but murine. Human relevance is plausible given the ubiquity of emulsifiers in processed food, but doses used were at the higher end. Human RCTs are needed.

FMT from anti-PD-1 responders combined with pembrolizumab led to clinical responses in 6 of 15 previously refractory melanoma patients.

• 016/15 patients achieved objective response or stable disease
• 02Responders showed increased CD8+ T cell infiltration and favorable gut microbiome shifts
• 03FMT was well-tolerated with no serious adverse events

Small, uncontrolled Phase I. Exciting signal but needs randomized Phase II confirmation. Selection bias in donor choice is a limitation.

The PREDICT-1 study showed that postprandial metabolic responses to identical meals vary dramatically between individuals, with microbiome composition as one contributing factor.

• 01Large inter-individual variation in glucose, insulin, and triglyceride responses to identical meals
• 02Gut microbiome composition explained part of this variation
• 03Genetic factors explained less than expected; meal context and individual factors dominated

Important for the personalized nutrition concept. Observational component limits causal claims. Commercial tie-in (ZOE) introduces conflict of interest but the science is peer-reviewed.

Overview of CTMR's translational microbiome research program at KI, covering vaginal, gut, and respiratory microbiomes with emphasis on clinical integration and biobank-linked population studies.

• 01Established one of Europe's largest microbiome biobanks linked to clinical registries
• 02Multi-omics integration (metagenomics, metabolomics, proteomics) as standard pipeline
• 03Focus on translating microbiome findings into clinical diagnostics and interventions

Programmatic rather than hypothesis-driven — but the infrastructure and cohort access it describes are world-class. Sets the stage for dozens of derivative studies.

Comprehensive review linking vaginal community state types to fertility, IVF success, miscarriage risk, and preterm birth, with emphasis on Lactobacillus crispatus dominance as a marker of reproductive health.

• 01CST-I (L. crispatus–dominant) consistently associated with better IVF outcomes
• 02Bacterial vaginosis–associated CST-IV linked to higher miscarriage and preterm birth risk
• 03Vaginal microbiome profiling may improve fertility treatment stratification

Synthesizes a heterogeneous literature convincingly. Causality remains unproven for most associations — interventional trials are the next step.

Showed that reduced gut microbiota diversity in HIV-infected individuals correlates with lower CD4 counts and higher systemic inflammation, independent of viral load and ART status.

• 01Low diversity linked to impaired CD4 recovery on ART
• 02Prevotella-rich communities associated with mucosal immune activation
• 03Microbiome diversity may serve as an independent predictor of immune reconstitution

Well-controlled for ART regimen and viral suppression. Cross-sectional component limits causal inference, but the immune-diversity link is robust.

Tracked gut microbiome disruption and resistome expansion during and after antibiotic courses for acute infections, showing prolonged persistence of resistance genes months after treatment.

• 01Antibiotic resistance genes expanded within days and persisted ≥ 6 months
• 02Microbiome diversity recovery was slower in patients receiving broader-spectrum agents
• 03Certain resistance genes transferred to commensal species during treatment

Important longitudinal design with matched controls. Sample size moderate but conclusions align with Palleja 2018 and add the clinical-infection context missing from that study.

Landmark study showing that germ-free mice exhibit altered anxiety-like behavior, motor activity, and neurochemistry compared to conventionally colonized mice. Colonization early in life — but not in adulthood — normalized behavior.

• 01Germ-free mice showed reduced anxiety and increased motor activity
• 02Altered expression of synaptic plasticity genes (PSD-95, synaptophysin) in germ-free brains
• 03Early-life colonization reversed behavioral changes; adult colonization did not — suggesting a critical developmental window

One of the foundational papers for the gut-brain axis field. Murine model limits direct human translation, but the critical-window finding has been replicated and is highly cited (~4000 citations).

Demonstrated that the gut microbiota regulates blood-brain barrier (BBB) permeability. Germ-free mice had increased BBB permeability from fetal life; colonization with short-chain fatty acid–producing bacteria restored barrier integrity.

• 01Germ-free mice had increased BBB permeability from intrauterine development
• 02Monocolonization with Clostridium tyrobutyricum (butyrate producer) restored BBB integrity
• 03Tight junction protein expression (occludin, claudin-5) was reduced in germ-free mice

Mechanistically elegant — connects SCFAs to BBB tight junctions. Murine, but the BBB pathway is conserved. Highly influential in establishing microbiome-brain barrier crosstalk.

Quantified the risk of ESBL-producing Enterobacteriaceae translocation from gut carriage to bloodstream infection in hospitalized patients, showing that intestinal ESBL burden predicts bacteremia.

• 01High intestinal ESBL-E abundance was independently associated with subsequent bacteremia
• 02Quantitative gut screening outperformed qualitative culture in risk prediction
• 03Targeted decolonization strategies may be justified for high-burden carriers

Clinically actionable — connects microbiome quantification to infection prevention. Single-center limits generalizability, but the dose-response relationship is compelling.

Comprehensive review of carbapenem resistance mechanisms, plasmid-mediated spread, and the role of gut colonization as a reservoir for resistant organisms in healthcare settings.

• 01Gut colonization is the primary reservoir for carbapenem-resistant Enterobacteriaceae (CRE) in hospitals
• 02Plasmid transfer between gut commensals and pathogens amplifies resistance spread
• 03Surveillance cultures and antimicrobial stewardship are the most effective containment strategies

Authoritative synthesis. Bridges genomics with clinical infection control — the gut-as-reservoir framing is now standard in antimicrobial stewardship guidelines.

Reviewed how H. pylori dominates and reshapes the gastric microbiota, and how eradication therapy causes collateral damage to gastric and gut microbial communities.

• 01H. pylori colonization reduces gastric microbial diversity dramatically
• 02Eradication therapy alters both gastric and intestinal microbiomes for months
• 03The gastric microbiota — long thought sterile — harbors a complex community modulated by acid, diet, and H. pylori status

Important for contextualizing H. pylori eradication beyond the pathogen — the collateral microbiome damage is underappreciated in clinical practice.

Characterized the vaginal microbiome in 345 young Swedish women with high HPV vaccination coverage and correlated microbial community state types with HPV infection status.

• 01Lactobacillus crispatus–dominant communities (CST-I) were associated with lower HPV prevalence
• 02Gardnerella vaginalis and L. iners enrichment correlated with higher HPV detection
• 03High vaccination coverage provided a unique setting to study residual HPV-microbiome interactions

Well-powered cross-sectional design in a vaccinated population. Cannot establish causality, but the CST-I protective association is consistent with other cohorts.

Identified a panel of host microRNAs in cervicovaginal fluid that predict vaginal community state type, opening a potential non-sequencing diagnostic pathway for vaginal dysbiosis.

• 01A 7-miRNA panel discriminated Lactobacillus-dominant from diverse communities
• 02Host miRNA expression reflects the local immune-microbial dialogue
• 03Potential for a cheaper, PCR-based alternative to 16S sequencing for vaginal microbiome screening

Novel approach bridging host and microbiome. Small discovery cohort needs independent validation, but the concept of host-RNA-as-proxy is compelling.

Describes the VaMiGyn cohort of 4,043 women recruited from the Swedish national cervical screening program, designed to explore vaginal microbiota associations with gynaecological health across age, hormonal status, and lifestyle factors.

• 01One of the largest population-based vaginal microbiome cohorts worldwide (n = 4,043)
• 02Linked microbiome data to national health registries for longitudinal outcome tracking
• 03Enables study of hormonal contraception, menopause, and lifestyle effects on vaginal communities

Cohort description rather than hypothesis test, but the scale and registry linkage are exceptional. Will generate high-impact derivative studies for years.

Showed that a few well-timed vaginal samples can predict long-term microbial community patterns, with CST stability varying by dominant Lactobacillus species and menstrual cycle phase.

• 01L. crispatus–dominant communities were the most temporally stable across menstrual cycles
• 02L. iners–dominant communities showed higher volatility and more frequent transitions to CST-IV
• 03Three strategically timed samples were sufficient to classify long-term vaginal microbiome patterns

Clinically actionable — reduces the sampling burden for microbiome profiling. The L. iners instability finding adds nuance to the 'Lactobacillus = healthy' simplification.

Went beyond species-level taxonomy to show that strain-level microdiversity within Lactobacillus populations is associated with preterm birth risk — women delivering preterm harbored more diverse L. crispatus strain populations.

• 01Higher intra-species diversity (microdiversity) of L. crispatus was linked to preterm birth
• 02Standard 16S community-level analysis missed this signal — metagenomics was required
• 03Suggests strain competition or instability as a mechanism, not just species presence/absence

Methodologically sophisticated — pushes the field past CST-level analysis. Moderate sample size for the preterm subgroup, but the microdiversity concept is a genuine advance.

Tracked vaginal microbiome changes through IVF embryo transfer and early pregnancy, finding that pre-transfer community composition influences implantation success.

• 01L. crispatus dominance at embryo transfer was associated with higher implantation rates
• 02Hormonal stimulation during IVF altered vaginal community composition in a subset of women
• 03Early pregnancy stabilized L. crispatus–dominant communities but not L. iners or diverse profiles

First longitudinal IVF-microbiome study from a Nordic cohort. Small but well-controlled. Supports the emerging case for pre-IVF microbiome screening.